Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

Typically, the first treatment for people with obesity ... Qsymia, pronounced Kyoo-sim-ee-uh, is informally known as obesity medicine experts’ best-kept weight loss secret.

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

The best treatment will depend on the individual, but the main options will be dietary measures and increased activity levels. Childhood obesity is reversible through treatment and lifestyle ...

The head of a company that helps brokers and employers manage obesity risk warned recently against assuming that Wegovy, Zepbound and their competitors will win the weight-control war. "The main ...

The operations mainly involve phony or illegal versions of Novo Nordisk’s diabetes drug Ozempic and its obesity drug Wegovy as well as Eli Lilly’s Mounjaro and Zepbound. All four drugs are in ...

Regeneron's CSO George Yancopoulos warns that GLP-1 weight-loss drugs like Ozempic may lead to rapid muscle loss, increasing ...

Is BMI the best choice of metric ... for treating obesity in kids younger than 12 years. How blockbuster obesity drugs create a full feeling — even before one bite of food The children who ...

More physicians are seeking out specialty training as treatment options for obesity expand. Here are six things to know about the current state of obesity training: 1. The approval of GLP-1 drugs ...

Rice is part of multiuniversity research team that has secured $34.9 million from ARPA-H to accelerate the development of a ...